XAGE (Longevity Health Holdings) EBIT: $-6.78 Mil (TTM As of Mar. 2026)

What is Longevity Health Holdings EBIT?

Longevity Health Holdings XAGE -23.30% 6 EBIT is $-6.78 Mil as of Mar. 2026. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review.

Longevity Health Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-1.43 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-6.78 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Longevity Health Holdings's annualized ROC % for the quarter that ended in Mar. 2026 was -346.74%. Longevity Health Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -1,487.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Longevity Health Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -928.49%.

Longevity Health Holdings (OTCPK:XAGE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Longevity Health Holdings's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-5.312 * ( 1 - 0% )	/	( (1.419	+	1.645)	/ 2 )
=	-5.312	/	1.532
=	-346.74 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.367	-	6.914	-	( 0.707	-	max(0, 7.916	-	1.95	+	0.707	))
=	1.419

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1.642	-	7.083	-	( 0.313	-	max(0, 8.349	-	1.263	+	0.313	))
=	1.645

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Longevity Health Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2026 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2025		Q: Mar. 2026
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-5.712	/	( ( (0.402 + max(-6.388, 0))	+	(0.366 + max(-7.187, 0)) )	/	2 )
=	-5.712	/	( ( 0.402	+	0.366 )	/	2 )
=	-5.712	/	0.384
=	-1,487.50 %

where Working Capital is:

	Working Capital		(Q: Dec. 2025 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.037	+	0.963	+	0.243)	-	(6.914	+	0	+	0.717)
=	-6.388

	Working Capital		(Q: Mar. 2026 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.049	+	0.735	+	0.166)	-	(7.083	+	0	+	1.054)
=	-7.187

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Longevity Health Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2026 )
	=	-6.778	/	0.730
	=	-928.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Health Holdings EBIT Related Terms

Longevity Health Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Longevity Health Holdings's EBIT can be seen below:

Longevity Health Holdings EBIT Chart

Longevity Health Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Dec25

EBIT

-3.98

-5.30

-15.32

-10.70

-6.85

Longevity Health Holdings Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBIT	Get a 7-Day Free Trial												-1.50	-1.88	-1.43	-2.04	-1.43

XAGE vs SNBH, SKVI, PG: EBIT Comparison

For the Household & Personal Products subindustry, Longevity Health Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Health Holdings EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Longevity Health Holdings's EV-to-EBIT falls into.

Save Embed

6GF Score

Longevity Health Holdings Inc XAGE

EBIT is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Longevity Health Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.78 Mil.

Frequently Asked Questions Learn more about EBIT →

What does a EBIT of $-6.78 Mil mean?

Longevity Health Holdings (XAGE) has a EBIT of $-6.78 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Longevity Health Holdings.

Is Longevity Health Holdings' EBIT too high?

Longevity Health Holdings' current EBIT is $-6.78 Mil. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.

How does Longevity Health Holdings' EBIT compare to SNBH and SKVI?

Longevity Health Holdings' EBIT of $-6.78 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBIT for a Consumer Packaged Goods company?

A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBIT mean?

A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Longevity Health Holdings. Longevity Health Holdings's current EBIT is $-6.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Longevity Health Holdings stock overvalued right now?

Longevity Health Holdings (XAGE) has a current EBIT of $-6.78 Mil. The current EBIT is $-6.78 Mil. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBIT calculated?

EBIT is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current EBIT is $-6.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Health Holdings Business Description

Industry Consumer Defensive Consumer Packaged Goods

Comparable Companies SNBH SKVI PG XPAR:OR LSE:ULVR CL BOM:500696 LSE:RKT KVUE KMB XTER:HEN3 EL CHD OSTO:ESSITY B XTER:BEI TSE:4452 CLX BOM:531642 BOM:532424 XMAD:PUIG

Address 2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203

Website http://www.healthxage.com

Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.

6GF Score

Get the complete analysis for XAGE

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26

Price

View XAGE Analysis

See EBIT data for all stocks →